Skip to main content

Capital Analysts, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1624758 FORT WASHINGTON, PA

Position in REGN

as of Mar 31, 2026 · filed May 14, 2026
Position Value
$401,772
-$1,144 QoQ
Shares Held
520
-0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Capital Analysts, LLC holds $1,026,985 across 15 Biotechnology names. REGN ranks #2 (39.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
520 $401,772

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $401,772 520
2025-12-31 $402,916 522
2025-09-30 $340,173 605
2025-06-30 $216,825 413
2025-03-31 $261,936 413
2024-12-31 $282,795 397
2024-09-30 $344,806 328
2024-06-30 $352,095 335
2024-03-31 $283,934 295
2023-12-31 $258,217 294
2023-09-30 $242,773 295
2023-06-30 $203,346 283
2023-03-31 $239,105 291
2022-12-31 $226,547 314
2022-09-30 $236,282 343
2022-06-30 $223,447 378
2022-03-31 $255,621 366
2021-12-31 $292,393 463
2021-09-30 $269,910 446
2021-06-30 $223,416 400
2021-03-31 $190,202 402
2020-12-31 $181,166 375
2020-09-30 $456,220 815
2020-06-30 $271,287 435
2020-03-31 $239,262 490